Corona virus is one of the viruses that has managed to confuse scientists, since the beginning of this deadly pathogen, scientists have come together to find a cure for this infection.
So far, there is no 100% effective drug that can prevent and treat this disease, although vaccines have been developed, they provide only partial protection, and along with vaccines many current drugs have been redirected to this infection.
The newest drug to join this list is gout, a type of arthritis that causes severe pain, redness, swelling and pain in joints, has been approved by the U.S. Food and Drug Administration (FDAAlthough this drug is primarily used to treat gout, it also has strong antiviral properties and can be used effectively against the Corona virus, according to a new study from the University of Georgia College of Veterinary Medicine. Scientific Reports
Medicine that can reduce infection and disease
According to the researchers in this study published on the “thehealthsite” website, the drug called ProbenecidIt has broad antiviral properties, and this makes it a prime candidate to fight the Corona virus and other common respiratory viruses.
Prevents the virus from multiplying
When viruses attack a human host, they make the cells multiply. According to the study, probenecid blocks this process and thus prevents the virus from infecting a person’s cells. This drug acts as a preventive treatment before exposure to the virus and also as a treatment after exposure.
The researchers came to this conclusion after conducting experiments on animal models against the Corona virus and influenza viruses, and said that studies in the human body are still ongoing, although experts recommend its use mainly after a person has tested positive for the Corona virus, the protective nature of the drug. She suggests it can also be given to people exposed to the virus to reduce the risk of infection and disease.
Safe and easy to use
Currently, healthcare professionals mainly use monoclonal antibodies and remdesivir to treat critically ill patients with corona, but these drugs are expensive and difficult to take because they are given intravenously. Oral, but researchers have not yet decided the correct dose for patients to fight the virus effectively.